Status:
COMPLETED
Extracorporeal Magnetic Innervation in Combination With Mirabegron in the Treatment of Overactive Bladder
Lead Sponsor:
Serdinsek Tamara
Conditions:
Overactive Bladder
Overactive Bladder Syndrome
Eligibility:
FEMALE
30-80 years
Phase:
NA
Brief Summary
The goal of this clinical trial is to learn about impact of extracorporeal electromagnetic stimulation in addition to medical treatment with mirabegron on the treatment of overactive bladder (OAB). Th...
Detailed Description
In this study the investigators are studying the impact of extracorporeal electromagnetic stimulation on the treatment of overactive bladder (OAB). For the research, the investigators will gather par...
Eligibility Criteria
Inclusion
- Female patients
- Age between 30 and 80 years
- Signs of OAB (including urinary frequency, urgency and urinary urgency incontinence)
Exclusion
- Positive urine culture
- Treatment with anticholinergics or mirabegron in the last 3 months
- Physiotherapy treatment of the pelvic floor muscles (e.g. pelvic floor exercises, electrical stimulation, etc.) in the last 3 months
- Stress incontinence
- Pelvic malignancies
- Pregnancy
- Cardiac pacemaker, implantable cardiac defibrillator
- Electronic device or metallic implant applied to areas between the lumbar region and lower extremities
Key Trial Info
Start Date :
October 14 2019
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
October 1 2023
Estimated Enrollment :
56 Patients enrolled
Trial Details
Trial ID
NCT06123364
Start Date
October 14 2019
End Date
October 1 2023
Last Update
November 9 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University Medical Centre Maribor
Maribor, Slovenia, 2000